BMEA
Biomea FusionยทNASDAQ
--
--(--)
Market Open: --
--
--(--)
Pre-Market: --
BMEA Profile
Biomea Fusion, Inc.
A clinical-stage biopharmaceutical company that develops novel covalent small molecules for cancers and metabolic diseases
Biological Technology
08/09/2017
04/16/2021
NASDAQ Stock Exchange
106
12-31
Common stock
900 Middlefield Road, 4th Floor, Redwood City, California 94063
--
Biomea Fusion, Inc., was incorporated under the laws of the State of Delaware on August 9, 2017. The Company is a clinical-stage biopharmaceutical company focused on the discovery and development of oral covalent small molecule drugs for the treatment of patients with metabolic diseases and genetically defined cancers.
